ADNAN CHOWDHURY: Open Payments
NPI 1144956525 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 70 payments from 14 companies in 2025. Trend: 2023 $763 · 2024 $891 · 2025 $1,331
Food & beverage: $1,331
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $437 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $232 |
| Madrigal Pharmaceuticals | 8 | $220 |
| Janssen Biotech, Inc. | 5 | $95 |
| PFIZER INC. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| VIVUS LLC | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
Products named: XIFAXAN, REZDIFFRA, RINVOQ, MAVYRET, TREMFYA, XELJANZ, CREON, DUPIXENT.
Industry payments across GA — which companies pay providers there.
